Perrigo ($PRGO) announced its fourth quarter revenue at $1.33 billion, beating consensus estimate. Its net loss for the quarter stood at $1.36 billion. For the full year, the company’s loss stood at $4.01 billion while its revenue was reported at $5.28 billion.
Taro Pharmaceuticals ($TARO) reported its revenue for the fourth quarter at $196.4 million while its earnings for the same period stood at $83 million. For the entire year, the company earned profit of $456.4 million, or $11.05 per share. Its revenue for the period stood at $879.4 million.